Cybin Reports Positive Topline Data From Phase 2 Study Of CYB003 in Major Depressive Disorder Nov 30, 2023
Numinus Reports Q4 & Full Year Fiscal 2023 Results, Including Greatly Reduced Cash Burn Rate Nov 29, 2023
